New flexible data-driven manufacturing models are emerging to address the pharmaceutical industry's need for greater operational efficiency, innovation and compliance.
This InfoBrief by IDC e Stratus analyzes the key drivers and challenges of this evolution and how pharmaceutical organizations need to address their strategic investments in Digital Transformation to achieve operational performance and innovation goals, while maintaining high levels of quality and regulatory compliance.
Read this InfoBrief to learn more about:
- The challenges of pharmaceutical manufacturing and the push towards digitally enabled industrial operations
- The centrality of data integration and IT/OT processes for innovative models of pharmaceutical production
- The strategic role of resilient, scalable and secure Edge Computing platforms.
*This InfoBrief is based on data analysis and insights from IDC Health Insights' extensive research on digital transformation in the pharmaceutical and life sciences industry. For this InfoBrief, IDC used life sciences data gathered from several recent surveys conducted around the world, including IDC's Future Enterprise Resiliency and Spending Survey. Respondents are executives from life sciences organizations that include pharmaceutical manufacturers, biotech companies, and medical device companies.